SecSonar.com

Lantheus Holdings, Inc. (LNTH)

Lantheus Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Lantheus Holdings, Inc. (LNTH) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $6.5B. Revenue grew 0.5% year-over-year and the company generated $354.1M in free cash flow. This page tracks LNTH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 808 employees · IPO Jun 25, 2015

Valuation

Valuation & price

$93.91 · as of May 17, 2026 · -14.5% vs 52w high

27.5

P/E ratio

Latest-FY diluted EPS

6.01

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$110$80.10$50.41Jul 25Dec 25Jun 26Jul 7, 25$79.19Jul 9, 25$83.49Jul 11, 25$81.31Jul 15, 25$81.26Jul 17, 25$73.60Jul 21, 25$71.56Jul 23, 25$73.31Jul 25, 25$72.93Jul 29, 25$72.20Jul 31, 25$71.19Aug 4, 25$71.46Aug 6, 25$51.87Aug 8, 25$57.20Aug 12, 25$53.90Aug 14, 25$54.47Aug 18, 25$55.97Aug 20, 25$56.14Aug 22, 25$58.21Aug 26, 25$55.66Aug 28, 25$55.50Sep 3, 25$55.15Sep 5, 25$54.75Sep 9, 25$55.07Sep 11, 25$54.99Sep 15, 25$51.74Sep 17, 25$50.84Sep 19, 25$50.41Sep 23, 25$52.06Sep 25, 25$51.47Sep 29, 25$50.62Oct 1, 25$51.63Oct 3, 25$53.83Oct 7, 25$51.84Oct 9, 25$52.39Oct 13, 25$54.59Oct 15, 25$56.52Oct 17, 25$55.60Oct 21, 25$57.70Oct 23, 25$56.52Oct 27, 25$58.13Oct 30, 25$55.49Nov 3, 25$56.82Nov 5, 25$57.23Nov 7, 25$51.07Nov 11, 25$53.37Nov 13, 25$53.12Nov 17, 25$52.50Nov 19, 25$52.79Nov 21, 25$55.82Nov 25, 25$59.06Nov 28, 25$58.87Dec 2, 25$58.55Dec 4, 25$61.87Dec 8, 25$62.27Dec 10, 25$60.82Dec 12, 25$66.62Dec 16, 25$65.17Dec 18, 25$64.84Dec 22, 25$68.01Dec 24, 25$66.68Dec 29, 25$67.34Jan 2, 26$67.27Jan 6, 26$69.68Jan 8, 26$67.85Jan 12, 26$67.48Jan 14, 26$65.60Jan 16, 26$64.25Jan 21, 26$66.44Jan 23, 26$67.51Jan 27, 26$67.89Jan 29, 26$66.68Feb 2, 26$66.50Feb 4, 26$65.93Feb 6, 26$64.89Feb 10, 26$67.17Feb 12, 26$68.72Feb 17, 26$71.27Feb 19, 26$73.18Feb 23, 26$73.42Feb 25, 26$75.72Mar 2, 26$76.30Mar 4, 26$77.84Mar 6, 26$72.56Mar 10, 26$83.22Mar 12, 26$80.42Mar 16, 26$78.50Mar 18, 26$80.24Mar 20, 26$76.43Mar 24, 26$74.24Mar 26, 26$76.36Mar 30, 26$73.09Apr 1, 26$75.70Apr 6, 26$75.89Apr 8, 26$80.03Apr 10, 26$80.59Apr 14, 26$82.74Apr 16, 26$83.92Apr 20, 26$83.97Apr 22, 26$82.88Apr 24, 26$84.33Apr 28, 26$83.55May 1, 26$85.50May 5, 26$85.82May 7, 26$91.00May 11, 26$94.07May 13, 26$96.46May 15, 26$93.91May 19, 26$92.89May 21, 26$94.47May 26, 26$100.06May 28, 26$99.62Jun 1, 26$97.13Jun 3, 26$100.25Jun 5, 26$100.98Jun 9, 26$99.98Jun 11, 26$104.32Jun 15, 26$104.67Jun 17, 26$103.19Jun 22, 26$106.20Jun 26, 26$109.80
$50.1152-week range$109.80
Loading valuation history…

Fundamentals

Key fundamentals

$6.5B

Market cap

0.5%

Revenue growth (YoY)

61.1%

Gross margin

$354.1M

Free cash flow (USD)

-$358.4M

Net debt

Net cash position

-2.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$301.9MFY 2017$331.4MFY 2018$343.4MFY 2019$347.3MFY 2020$339.4MFY 2021$425.2MFY 2022$935.1MFY 2023$1.3BFY 2024$1.5BFY 2025$1.5B
$301.9M$1.5B

Free cash flow by year

2016 → 2025

FY 2016$42.2MFY 2017$37.2MFY 2018$41.1MFY 2019$58.3MFY 2020$3.9MFY 2021$41.8MFY 2022$263.4MFY 2023$258.7MFY 2024$493.1MFY 2025$354.1M
$42.2M$354.1M

Gross margin by year

2021 → 2025

FY 202144.1%FY 202262.2%FY 202354.7%FY 202464.4%FY 202561.1%
44.1%61.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventEquity Incentive Plan UpdateMay 1, 2026Filing

Questions

Frequently asked questions

What is Lantheus Holdings, Inc.'s market cap?

Lantheus Holdings, Inc. (LNTH) has a market capitalization of $6.5B.

What is LNTH's P/E ratio?

LNTH trades at a price-to-earnings ratio of 27.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is LNTH's price-to-book (P/B) ratio?

LNTH trades at 6.01 times book value per share.

Are insiders buying LNTH stock?

SEC Form 4 filings show no open-market insider buys at Lantheus Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

INDV

Indivior Pharmaceuticals Inc

$4.5B

AMRX

Amneal Pharmaceuticals, Inc.

$4.2B

SUPN

Supernus Pharmaceuticals, Inc.

$2.7B

HCM

HUTCHMED (China) Limited

$2B

BHC

Bausch Health Companies Inc.

$2B

ANIP

ANI Pharmaceuticals, Inc.

$1.8B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.